Long-term generation of human mast cells in serum-free cultures of CD34+ cord blood cells stimulated with stem cell factor and interleukin-3.

The generation of murine mast cells is supported by several cytokines, and mast cell lines are frequently established in long-term cultures of normal murine marrow cells. In contrast, growth of human mast cells was initially dependent on coculture with murine fibroblasts. The growth factor produced by murine fibroblasts and required to observe differentiation of human mast cells is attributable in part to stem cell factor (SCF). However, other factors are likely involved. We have previously shown that the combination of SCF and interleukin-3 (IL-3) efficiently sustains proliferation and differentiation of colony-forming cells (CFCs) from pre-CFC enriched from human umbilical cord blood by CD34+ selection. With periodic medium changes and the addition of fresh growth factors, five consecutive cultures of different cord blood samples gave rise to differentiated cells and CFCs for more than 2 months. Although differentiated cells continued to be generated for more than 5 months, CFCs were no longer detectable by day 50 of culture. The cells have the morphology of immature mast cells, are Toluidine blue positive, are karyotypically normal, are CD33+, CD34-, CD45+, c-kit-, and c-fms-, and die in the absence of either SCF or IL-3. These cells do not form colonies in semisolid culture and are propagated in liquid culture stimulated with SCF and IL-3 at a seeding concentration of no less than 10(4) cells/mL. At refeedings, the cultures contain a high number (> 50%) of dead cells and have a doubling time ranging from 5 to 12 days. This suggests that subsets of the cell population die because of a requirement for a growth factor other than SCF or IL-3. These results indicate that the combination of cord blood progenitor and stem cells, plus a cocktail of growth factors including SCF and IL-3, is capable with high efficiency of giving rise in serum-deprived culture to human mast cells that behave like factor-dependent cell lines. These cells may represent a useful tool for studies of human mast cell differentiation and leukemia.

[1]  P. Besmer,et al.  Role of kit-ligand in proliferation and suppression of apoptosis in mast cells: basis for radiosensitivity of white spotting and steel mutant mice , 1994, The Journal of experimental medicine.

[2]  D. Dombrowicz,et al.  Abolition of anaphylaxis by targeted disruption of the high affinity immunoglobulin E receptor α chain gene , 1993, Cell.

[3]  J. Adamson,et al.  Long-term generation of colony-forming cells (CFC) from CD34+ human umbilical cord blood cells. , 1993, Leukemia & lymphoma.

[4]  E. Johnson,et al.  Mediator release from mast cells by nerve growth factor. Neurotrophin specificity and receptor mediation. , 1993, The Journal of biological chemistry.

[5]  H. Langen,et al.  Mechanism of kit ligand, phorbol ester, and calcium-induced down-regulation of c-kit receptors in mast cells. , 1993, The Journal of biological chemistry.

[6]  C. Heusser,et al.  Human peripheral blood basophils primed by interleukin 3 (IL-3) produce IL-4 in response to immunoglobulin E receptor stimulation , 1993, The Journal of experimental medicine.

[7]  K. Zsebo,et al.  Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligand. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[8]  K. Zsebo,et al.  Isolation of rat bone marrow mast lineage cells using Thy 1.1 and rat stem cell factor , 1992, Journal of cellular physiology.

[9]  K. Zsebo,et al.  Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term culture. , 1992, Blood.

[10]  T. Luft,et al.  Growth of human umbilical-cord blood in longterm haemopoietic cultures , 1992, The Lancet.

[11]  S. Bischoff,et al.  Effect of nerve growth factor on the release of inflammatory mediators by mature human basophils. , 1992, Blood.

[12]  J. Adamson,et al.  Long-term generation of colony-forming cells in liquid culture of CD34+ cord blood cells in the presence of recombinant human stem cell factor. , 1992, Blood.

[13]  S. McColl,et al.  Interleukin‐4 and nerve growth factor can act as cofactors for interleukin‐3‐induced histamine production in human umbilical cord blood cells in serum‐free culture , 1992, British journal of haematology.

[14]  D. Williams,et al.  Mast cell growth factor (c-kit ligand) supports the growth of human multipotential progenitor cells with a high replating potential. , 1991, Blood.

[15]  K. Zsebo,et al.  Murine mast cell colony formation supported by IL‐3, IL‐4, and recombinant rat stem cell factor, ligand for c‐kit , 1991, Journal of cellular physiology.

[16]  J. Adamson,et al.  Effects of recombinant human stem cell factor (SCF) on the growth of human progenitor cells in vitro , 1991, Journal of cellular physiology.

[17]  M. Tsai,et al.  Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem cell factor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[18]  M. Tsai,et al.  The rat c-kit ligand, stem cell factor, induces the development of connective tissue-type and mucosal mast cells in vivo. Analysis by anatomical distribution, histochemistry, and protease phenotype , 1991, The Journal of experimental medicine.

[19]  Y. Kitamura,et al.  Nerve growth factor induces development of connective tissue-type mast cells in vitro from murine bone marrow cells , 1991, The Journal of experimental medicine.

[20]  T. Mosmann,et al.  Interleukin 10: a novel stimulatory factor for mast cells and their progenitors , 1991, The Journal of experimental medicine.

[21]  C. March,et al.  Identification of a ligand for the c-kit proto-oncogene , 1990, Cell.

[22]  David A. Williams,et al.  Stem cell factor is encoded at the SI locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor , 1990, Cell.

[23]  K. Nocka,et al.  Candidate ligand for the c‐kit transmembrane kinase receptor: KL, a fibroblast derived growth factor stimulates mast cells and erythroid progenitors. , 1990, The EMBO journal.

[24]  A. Dvorak,et al.  Development of human mast cells in vitro. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[25]  J. Adamson,et al.  Selection of lineage-restricted cell lines immortalized at different stages of hematopoietic differentiation from the murine cell line 32D , 1989, The Journal of cell biology.

[26]  T. Enver,et al.  Erythropoietin changes the globin program of an interleukin 3-dependent multipotential cell line. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. Adamson,et al.  In vitro differentiation of human granulocyte/macrophage and erythroid progenitors: comparative analysis of the influence of recombinant human erythropoietin, G-CSF, GM-CSF, and IL-3 in serum-supplemented and serum-deprived cultures. , 1988, Blood.

[28]  A. Ullrich,et al.  Human proto‐oncogene c‐kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. , 1987, The EMBO journal.

[29]  A. Migliaccio,et al.  Cloning of human erythroid progenitors (BFU‐E) in the absence of fetal bovine serum , 1987, British journal of haematology.

[30]  D. Rennick,et al.  Interleukin 4 (B-cell stimulatory factor 1) can enhance or antagonize the factor-dependent growth of hemopoietic progenitor cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[31]  D. Tweardy,et al.  Cytokine-dependent granulocytic differentiation. Regulation of proliferative and differentiative responses in a murine progenitor cell line. , 1987, Journal of immunology.

[32]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[33]  K. Arai,et al.  A cloned MCGF cDNA encodes a multilineage hematopoietic growth factor: multiple activities of interleukin 3. , 1985, Journal of immunology.

[34]  P. Arcari,et al.  The complete sequence of a full length cDNA for human liver glyceraldehyde-3-phosphate dehydrogenase: evidence for multiple mRNA species. , 1984, Nucleic acids research.

[35]  D. Boettiger,et al.  Continuous in vitro generation of multipotential stem cell clones from src-infected cultures , 1984, Nature.

[36]  J. Greenberger,et al.  Demonstration of permanent factor-dependent multipotential (erythroid/neutrophil/basophil) hematopoietic progenitor cell lines. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[37]  R. Good,et al.  Enrichment for CFU-C from murine and human bone marrow using soybean agglutinin. , 1982, Blood.

[38]  D. Zucker‐Franklin Ultrastructural evidence for the common origin of human mast cells and basophils , 1980 .

[39]  D. Golde,et al.  Long-term human bone marrow cultures. , 1980, Blood.

[40]  A. Gotoh,et al.  Ligand-dependent polyubiquitination of c-kit gene product: a possible mechanism of receptor down modulation in M07e cells. , 1994, Blood.

[41]  A. Gotoh,et al.  Ligand-dependent polyubiquitination of c-kit gene product: a possible mechanism of receptor down modulation in M07e cells , 1994 .

[42]  J. Renauld,et al.  Cloning and expression of a cDNA for the human homolog of mouse T cell and mast cell growth factor P40. , 1990, Cytokine.

[43]  J. Adamson,et al.  Selection of lineage-restricted cell lines immortalized at different stages of hematopoietic differentiation from the murine cell line 32 D. , 1989, Progress in clinical and biological research.

[44]  A. Frischauf,et al.  Isolation of genomic DNA. , 1987, Methods in enzymology.

[45]  D. Zucker‐Franklin,et al.  Ultrastructural evidence for the common origin of human mast cells and basophils. , 1980, Blood.